Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Treatment of High-grade Extremity Soft Tissue and Non-metastatic Sarcomas

NCT02812654 is registered in ClinicalTrials.gov with AC Camargo Cancer Center as lead sponsor.

NCT NCT02812654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02812654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Treatment of High-grade Extremity Soft Tissue and Non-metastatic Sarcomas
Lead sponsor
AC Camargo Cancer Center
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2015
Completion date
March 31, 2019
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma, soft tissue